Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.81 USD | -0.06% | +2.77% | +26.13% |
Business Summary
Number of employees: 154
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gregory Divis
CEO | Chief Executive Officer | 57 | 03/17/03 |
Thomas McHugh
DFI | Director of Finance/CFO | 59 | 02/19/02 |
Scott Macke
COO | Chief Operating Officer | - | 01/14/01 |
Jerad G. Seurer
CMP | Compliance Officer | - | 01/17/01 |
Jennifer Gudeman
CTO | Chief Tech/Sci/R&D Officer | - | 07/20/07 |
Jason Vaughn
CTO | Chief Tech/Sci/R&D Officer | - | 02/19/02 |
Denise Strauss
SAM | Sales & Marketing | - | 02/21/02 |
Angela Woods
HRO | Human Resources Officer | - | 01/21/01 |
Richard Kim
PRN | Corporate Officer/Principal | 54 | 15/21/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Ende
BRD | Director/Board Member | 55 | 01/18/01 |
Gregory Divis
CEO | Chief Executive Officer | 57 | 03/17/03 |
Mark McCamish
BRD | Director/Board Member | 72 | 05/19/05 |
Geoffrey Glass
CHM | Chairman | 50 | 01/18/01 |
Linda Palczuk
BRD | Director/Board Member | 62 | 01/18/01 |
Peter Thornton
BRD | Director/Board Member | 59 | 01/17/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 90,576,998 | 86,139,858 ( 95.10 %) | 0 | 95.10 % |
Stock B | 0 | 5,194,000 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.13% | 1.61B | |
+25.83% | 661B | |
+26.46% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.85% | 231B | |
+5.04% | 200B | |
-8.96% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- AVDL Stock
- Company Avadel Pharmaceuticals plc